Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Colla

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|June 25, 2015
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletionMonica Cabrero, Yiting Yu, Amit Verma, et al.
Leukemia|June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemiaYue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Cell Reports. Medicine|February 1, 2025
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemiaKristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
Blood|September 13, 2007
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesisSimona Colla, Sara Tagliaferri, Francesca Morandi, et al.
Blood|June 25, 2025
Clinical and molecular features of immunodeficiency in patients with telomere biology disordersLuiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, et al.
Blood|March 22, 2003
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Mirca Lazzaretti, et al.
Haematologica|April 20, 2023
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cellsYannan Jia, Lina Han, Cassandra L Ramage, et al.
The Lancet. Oncology|December 8, 2016
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyKoichi Takahashi, Feng Wang, Hagop Kantarjian, et al.
Blood|May 27, 2006
The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activityBhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|June 25, 2015
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletionMonica Cabrero, Yiting Yu, Amit Verma, et al.
Leukemia|June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemiaYue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Cell Reports. Medicine|February 1, 2025
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemiaKristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
Blood|September 13, 2007
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesisSimona Colla, Sara Tagliaferri, Francesca Morandi, et al.
Blood|June 25, 2025
Clinical and molecular features of immunodeficiency in patients with telomere biology disordersLuiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, et al.
Blood|March 22, 2003
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Mirca Lazzaretti, et al.
Haematologica|April 20, 2023
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cellsYannan Jia, Lina Han, Cassandra L Ramage, et al.
The Lancet. Oncology|December 8, 2016
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyKoichi Takahashi, Feng Wang, Hagop Kantarjian, et al.
Blood|May 27, 2006
The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activityBhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Pageof 10